Stock market today: Dr. Reddy’s to Yes Bank— 274 BSE-listed shares hit 52-week low. Do you own any?

Stock market today: Dr. Reddy’s to Yes Bank— 274 BSE-listed shares hit 52-week low. Do you own any?

Published12 Mar 2025, 03:34 PM IST

Stock market today: Dr. Reddy’s to Yes Bank— 274 BSE-listed shares hit 52-week low.

(more to come)

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business News Markets Stock MarketsStock market today: Dr. Reddy’s to Yes Bank— 274 BSE-listed shares hit 52-week low. Do you own any?

MoreLess

First Published:12 Mar 2025, 03:34 PM IST

Source link

Consider these global ETFs as Trump’s tariffs push the world away from the U.S.

Market strategist Keith McCullough: Stock markets in Europe and Asia will be stronger than the U.S. Source link

Indian equity markets closed today for Holi festival

AIMPWAMarch 14, 2025

Indian equity markets are closed today, Friday, March 14, in observance of Holi, the vibrant festival of colors celebrated across the nation. The holiday, which marks the arrival of spring, has led to a pause in trading activity on the domestic stock exchanges. The short trading week will give the market participants some extra time...

The S&P 500 is in a correction. What history says happens next.

AIMPWAMarch 14, 2025

The market pullback to Thursday’s close brings the loss to just over 10% from the record close of 6144.15 on Feb. 19, has been quick. It was only 16 trading days ago that the S&P 500 was at a record high, according to Dow Jones Market Data. The Nasdaq Composite is already in a correction...

Gold tops $3,000. Here’s what investors joining the gold rush need to know.

AIMPWAMarch 14, 2025

The value of gold has nearly doubled in the past five years, crossing the $3,000-an-ounce threshold for the first time ever late Thursday — and the precious metal’s latest move may be signaling a structural shift in the sector that may feed long-term strength. Source link

Glenmark expands diabetes portfolio with new Empagliflozin treatments

AIMPWAMarch 14, 2025

Glenmark Pharmaceuticals announced today the launch of Empagliflozin and its fixed-drug combinations in India under the brand names Glempa, Glempa-L, and Glempa-M. The shares of Glenmark Pharmaceuticals Limited were trading today at ₹1,390.85 up by ₹9.35 or 0.67 per cent on the NSE today at 12.37 pm. The SGLT2 inhibitor and its combinations are designed...